Search Count: 19
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1S |
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1V |
 |
Organism: Rattus norvegicus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2019-07-31 Classification: SIGNALING PROTEIN Ligands: GOL, GDP |
 |
Organism: Rattus norvegicus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-07-31 Classification: SIGNALING PROTEIN Ligands: GDP, GOL |
 |
Organism: Oryza sativa subsp. japonica
Method: ELECTRON MICROSCOPY Release Date: 2019-07-03 Classification: TRANSPORT PROTEIN |
 |
Identification Of A New Class Of Potent Cdc7 Inhibitors Designed By Putative Pharmacophore Model: Synthesis And Biological Evaluation Of 2,3-Dihydrothieno[3,2-D]Pyrimidin-4(1H)-Ones
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.15 Å Release Date: 2017-03-29 Classification: TRANSFERASE |
 |
Identification Of A New Class Of Potent Cdc7 Inhibitors Designed By Putative Pharmacophore Model: Synthesis And Biological Evaluation Of 2,3-Dihydrothieno[3,2-D]Pyrimidin-4(1H)-Ones
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.33 Å Release Date: 2017-03-29 Classification: TRANSFERASE Ligands: 81G |
 |
Lysozyme Soaked With A Ruthenium Based Corm With A Methione Oxide Ligand (Complex 6B)
Organism: Gallus gallus
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2014-12-10 Classification: HYDROLASE Ligands: CL, NA, RU, CMO, GOL |
 |
Organism: Gallus gallus
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2014-12-10 Classification: HYDROLASE Ligands: CL, NA, FMT, CMO, RU |
 |
Organism: Gallus gallus
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2014-12-10 Classification: HYDROLASE Ligands: CL, NA, RU, CMO |
 |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2014-01-29 Classification: LIGASE Ligands: TRP, BME, K |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-11-27 Classification: APOPTOSIS Ligands: LC3 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2013-11-27 Classification: APOPTOSIS Ligands: LC6 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2013-11-27 Classification: APOPTOSIS Ligands: LC6, PO4 |
 |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.91 Å Release Date: 2013-05-01 Classification: LIGASE |
 |
Organism: Gallus gallus
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2013-02-06 Classification: HYDROLASE Ligands: K3G, NA, CL |
 |
Solution Structure Of Human 53Bp1 Tandem Tudor Domains In Complex With A Histone H4K20Me2 Peptide
|
 |
Crystal Of Plasmodium Falciparum Tyrosyl-Trna Synthetase (Pftyrrs)In Complex With Adenylate Analog
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2012-07-25 Classification: LIGASE Ligands: TYR, AMP |
 |
The Structure Of An Interleukin-1 Beta Mutant With Reduced Bioactivity Shows Multiple Subtle Changes In Conformation That Affect Protein-Protein Recognition
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 1994-01-31 Classification: CYTOKINE |